Jeff Geier
Vice President of Investor Relations
Replay available
Molina Healthcare Inc (NYSE: MOH) Q4 2025 earnings conference call, held 2026-02-06. Replay captured from the company's public earnings webcast.

Vice President of Investor Relations
President and Chief Executive Officer
Chief Financial Officer
Nefron Research Analyst
UBS Analyst
Wolfe Research Analyst
Wells Fargo Analyst
Mizuho Securities Analyst
Barclays Analyst
Cantor Fitzgerald Analyst
Analyst
Analyst
Analyst
Analyst
Good day and welcome to the Molina Healthcare fourth quarter 2025 conference call. All participants will be in a listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on a touch-tone phone. To withdraw your question, please press star then two. Please note that this event is being recorded I would now like to turn the conference over to Jeff Geier, Vice President of Investor Relations. Please go ahead. Good morning, and welcome to Molina Healthcare's fourth quarter and full year 2025 earnings call. Joining me today are Molina's President and CEO, Joe Zabretzky, and our CFO, Mark Kine. A press release announcing our fourth quarter and full year 2025 earnings was distributed after the market closed yesterday and is available on our Investor Relations website. Shortly after the conclusion of this call, a replay will be available for 30 days. The numbers to access the replay are in the earnings release. For those of you who listened to the rebroadcast of this presentation, we remind you that all of the remarks are made as of today, Friday, February 6, 2026, and have not been updated subsequent to the initial earnings call. On this call, we will refer to certain non-GAAP measures. A reconciliation of these measures with the most directly comparable GAAP measures can be found in the fourth quarter and full year 2025 earnings release. During the call, we will be making certain forward-looking statements, including, but not limited to, statements regarding our 2026 guidance, the medical cost trend and our projected MCRs, Medicaid rate adjustments and updates, our recent Florida CMS R...